[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544717":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":27,"locations":27,"responsibleParty":28,"collaborators":27,"id":32,"slug":27,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":27,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":27,"enrollmentInfo":41,"targetDuration":27,"studyType":44,"phases":45,"briefSummary":47,"conditions":48,"keywords":27,"overallStatus":50,"whyStopped":27,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":27},{"fullName":5,"class":6},"Rambam Health Care Campus","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"continuous oxytocin infusion","EXPERIMENTAL","continuous oxytocin infusion - women will continue to receive a continuous oxytocin infusion from start of labor augmentation until delivery.",[13],"Drug: Pitocin Injectable Product",{"label":15,"type":16,"description":17,"interventionNames":18},"intermittent oxytocin infusion","ACTIVE_COMPARATOR","intermittent oxytocin infusion - oxytocin transfusion will be discontinued after 8 hours if the woman does not go into active labor, or does not deliver in that period of time.\n\nThe second course of oxytocin will be renewed after 6 hours if the woman hasn't progressed into labor or hasn't given birth yet.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Pitocin Injectable Product","The primary dose of oxytocin is 1.0 mU\u002Fmin, with an incremental increase by 2.5 mU\u002Fmin every 30 minutes, until 20.0 mU\u002Fmin, tittered to a target of 3-5 contractions in a 10-minute period, or active labor (dilatation \\> 6 cm).",[9,15],[26],"Synthetic Oxytocin",null,{"type":29,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"PRINCIPAL_INVESTIGATOR","Hiba Abu Rass MD","Resident in OB-GYN, Principal Investigator","100544717",false,"NCT06372522","Oxytocin in Multiparous Women","Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor in Multiparous Pregnant Women","Inclusion Criteria:\n\n* multiparous women (women who have given birth one or more times in the past) with a singleton pregnancy that are admitted for induction of labor.\n* Women at gestational age of 370\u002F7 or more.\n* Vertex presentation.\n\nExclusion Criteria:\n\n* Age 18 and under.\n* High order gestation.\n* Women with contraindication for vaginal delivery.\n* Previous cesarean delivery.\n* Active labor.\n* Documented fetal anomalies.",true,"FEMALE","18 Years",{"count":42,"type":43},166,"ESTIMATED","INTERVENTIONAL",[46],"NA","This is a randomized controlled trial investigating whether continuous oxytocin infusion in multiparous women shortens time to delivery, without altering maternal or neonatal outcomes, in augmented deliveries, compared to intermittent infusion.",[49],"Pregnancy Related","NOT_YET_RECRUITING","2024-04-17",{"date":53,"type":54},"2024-04-18","ACTUAL",{"date":56,"type":43},"2024-04",{"date":58,"type":43},"2027-04",{"name":5,"class":6}]